MedTrace Logo

A Chatbot Intervention for Reducing HPV Vaccine Hesitancy

NCT05959564 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 456

Last updated 2024-10-21

Study results available
· View outcomes & findings →

Summary

The goal of this project is to test the efficacy of a chatbot intervention for reducing HPV vaccine hesitancy among African American parents. An online experiment will be conducted to test the effectiveness of the chatbot intervention with African American parents. Results of this project will inform future communication interventions for reducing vaccine hesitancy among African American parents.

Conditions

Interventions

BEHAVIORAL

Personalized Chatbot Intervention

In this intervention, participants will first see a standard CDC HPV vaccine message. After that they will be invited to interact with a chatbot designed to deliver additional HPV vaccine messages, which are tailored to their personalities.

BEHAVIORAL

Non-Personalized Chatbot Intervention

In this intervention, participants will first see a standard CDC HPV vaccine message. After that they will be invited to interact with a chatbot designed to deliver additional HPV vaccine messages, which are not tailored to their personalities.

BEHAVIORAL

No Chatbot Control

In this intervention, participants will see a standard CDC HPV vaccine message only and will not interact with any chatbot.

Sponsors & Collaborators

  • University of Maryland, College Park

    lead OTHER

Principal Investigators

  • Xiaoli Nan · University of Maryland, College Park

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-26
Primary Completion
2023-08-08
Completion
2023-08-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05959564 on ClinicalTrials.gov